Smith+Nephew Sets 2 March 2026 Date for 2025 Full-Year Results
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Smith & Nephew Snats ( (SNN) ) has provided an update.
Smith+Nephew announced that it will publish its full-year results for the year ended 31 December 2025 on 2 March 2026 at 7:00am GMT (2:00am EST), with a follow-up conference call for financial analysts at 8:30am GMT (3:30am EST). The timetable signals the next key event in the company’s financial calendar for investors and analysts, who will be watching the results for indications of performance across its core orthopaedics, sports medicine and advanced wound management franchises and any implications for its standing in the global medtech market.
The most recent analyst rating on (SNN) stock is a Hold with a $34.91 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Neutral.
Smith & Nephew Snats’ strong financial performance and positive earnings call are the main drivers of its stock score. However, bearish technical indicators and a high P/E ratio temper the overall outlook. The company’s strategic initiatives, such as the share buyback, reflect confidence in its financial health, but challenges in emerging markets and tariff impacts pose risks.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Smith+Nephew is a global medical technology company focused on the repair, regeneration and replacement of soft and hard tissue, operating through three main business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Founded in Hull, UK in 1856, it now operates in more than 100 countries, employs around 18,000 people and generated $5.8 billion in sales in 2024, and is a constituent of the FTSE 100 with listings in London and New York.
Average Trading Volume: 706,481
Technical Sentiment Signal: Strong Buy
Current Market Cap: $14.81B
For a thorough assessment of SNN stock, go to TipRanks’ Stock Analysis page.
